ClinicalTrials.gg
RecruitingNCT07362550TWIN-BD12Updated Jan 23, 2026

Effects of 12-Week Balanced Diet on Body Composition & Metabolic Parameters in Twins

An interventional study of Balanced Diet in Healthy Adults, sponsored by University of Veterinary and Animal Sciences, Lahore - Pakistan. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-23.

Sponsored by University of Veterinary and Animal Sciences, Lahore - Pakistan · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Twin study in Lahore will assess genetic vs. environmental effects on diet and metabolism. Over 12 weeks, monozygotic and dizygotic twins will follow a WHO-aligned balanced diet. Body composition, metabolic markers, and adherence will be measured. Monozygotic twins are expected to show greater similarity in response, clarifying personalized nutrition strategies in Pakistan.

Read the detailed description

Background: Twin studies help separate genetic and environmental influences on diet and metabolic health. With rising obesity and metabolic disorders in Pakistan, there is no twin-based dietary intervention data. Filling this gap is essential for developing effective, evidence-based personalized nutrition strategies.

Hypothesis: The null hypothesis states that there will be no difference in dietary response or within-pair similarity between monozygotic and dizygotic twins. The alternative hypothesis suggests that monozygotic twins will show greater similarity in diet response and that the balanced diet will significantly improve metabolic outcomes.

Methodology: A 12-week randomized controlled trial will recruit Monozygotic and Dizygotic twins aged 18-60 years in Lahore, Pakistan. Participants of interventional group will follow a WHO-aligned balanced diet. Body composition, metabolic markers, and dietary adherence will be assessed at baseline and week 12.

Statistical Design: Analyses will be conducted in SPSS using paired t-tests for within-pair comparisons and independent t-tests for Monozygotic vs. Dizygotic differences. Effect sizes will be calculated, with significance set at p \< 0.05.

Expected Outcomes: The study is expected to show that the balanced diet improves metabolic and body composition outcomes, with monozygotic twins displaying more similar responses than dizygotic twins. These findings will clarify genetic vs. environmental effects and support more targeted nutrition recommendations in Pakistan.

02

Conditions studied

  • Healthy Adults

Keywords

  • Monozygotic
  • Dizygotic
  • Metabolic Parameters
03

In context

Lead sponsor

University of Veterinary and Animal Sciences, Lahore - Pakistan is the lead sponsor of 27 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female twins aged 18-60 years.
  • Confirmed zygosity (MZ or DZ) based on a validated twin zygosity questionnaire.
  • Both twins willing to participate for the entire intervention period.
  • Free from chronic diseases requiring specialized diets (e.g., type 1 diabetes, celiac disease).
  • Not currently enrolled in another dietary or lifestyle intervention study.

Exclusion criteria

Exclusion Criteria:

  • Pregnant or lactating women.
  • Use of lipid-lowering, glucose-lowering, or weight-loss medications in the past 3 months.
  • Major gastrointestinal disorders or conditions affecting nutrient absorption.
  • Unwillingness to follow individualized dietary counseling or complete study assessments.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Habitual Diet

    Control group will remain on habitual Diet.

  • Experimental
    Balanced Diet

    12-week culturally adapted WHO-aligned balanced diet emphasizing whole grains, lean proteins, healthy fats, fruits, and vegetables, individualized based on basal metabolic rate (BMR) and physical activity levels will be provided to interventional arm.

    Other: Balanced Diet

Interventions

  • OtherBalanced Diet

    12-week culturally adapted WHO-aligned balanced diet emphasizing whole grains, lean proteins, healthy fats, fruits, and vegetables. Macronutrient composition: 45-65% carbohydrates, 20-35% fats, 10-20% protein. Individualized based on basal metabolic rate (BMR) and physical activity. Weekly counseling and monitoring through dietary recalls and photographic diaries. This intervention aims to assess the effects of a balanced diet on body composition and metabolic parameters in monozygotic and dizygotic twins.

06

What researchers measure

Primary outcomes

  1. Change in Body Fat Percentage (%)

    Change in total body fat percentage measured using the InBody analyzer to assess the effect of a 12-week balanced diet intervention.

    Time frame: Baseline and after 12-Week of Intervention.

Secondary outcomes

  1. Change in Fasting Plasma Glucose (mg/dL)

    Change in fasting plasma glucose concentration measured to assess the metabolic effect of the 12-week balanced diet intervention. Unit: mg/dL Tool: Venous blood sample, enzymatic laboratory method

    Time frame: Baseline and after 12 weeks

  2. Change in Lipid Profile (mg/dL)

    Change in fasting serum lipid concentrations measured to assess metabolic response to the 12-week balanced diet intervention. Includes: Total Cholesterol (mg/dL) Low-Density Lipoprotein (LDL-C, mg/dL) High-Density Lipoprotein (HDL-C, mg/dL) Triglycerides (mg/dL) Unit: mg/dL Tool: Venous blood sample, standard enzymatic laboratory methods

    Time frame: Baseline and after 12 weeks

  3. To compare within-pair similarity of Dietary Response

    To compare the within-pair similarity of diet response between Monozygotic (MZ) and Dizygotic (DZ) twins, allowing estimation of genetic versus environmental contributions to dietary effects.

    Time frame: Baseline and after 12-Weeks of intervention

07

Study locations

1 of 1 sites recruiting
  • University of Veterinary and Animal Sciences, Lhr.
    Lahore, Punjab Province 54000, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2026; primary completion for Apr 2026, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 17, 2025
First posted
Jan 23, 2026
StartEst.
Jan 17, 2026
Primary completionEst.
Apr 19, 2026
CompletionEst.
Apr 25, 2026
Last update
Jan 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07362550
Lead sponsor
University of Veterinary and Animal Sciences, Lahore - Pakistan
Responsible party
Qaisar Raza (Assistant Professor, University of Veterinary and Animal Sciences, Lahore - Pakistan) — Principal investigator
First posted
Jan 23, 2026
Start date
Jan 17, 2026 (estimated)
Primary completion
Apr 19, 2026 (estimated)
Completion
Apr 25, 2026 (estimated)
Last update
Jan 23, 2026

Study contacts

Momina Azhar Mehmood, Postgraduate
Contact
mominaazhar1612@gmail.com
+92-3227642452
Qaisar Raza, Ph.D
Contact
qaisar.raza@uvas.edu.pk
+92-3002479044
Qaisar Raza, Ph.D
principal investigator · UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES, LHR.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion